Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Saregama India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 10:54 am

Market Cap 9,475 Cr.
Current Price 491
High / Low 689/339
Stock P/E47.9
Book Value 80.5
Dividend Yield0.92 %
ROCE19.6 %
ROE14.2 %
Face Value 1.00
PEG Ratio4.96

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Saregama India Ltd

Competitors of Saregama India Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Hathway Bhawani Cabletel & Datacom Ltd 13.2 Cr. 16.3 23.7/14.9 1.990.00 %2.26 %2.26 % 10.0
G V Films Ltd 114 Cr. 0.61 1.04/0.52 0.610.00 %2.27 %2.08 % 1.00
Encash Entertainment Ltd 11.3 Cr. 29.0 / 21.30.00 %3.81 %3.93 % 10.0
Diksat Transworld Ltd 260 Cr. 148 149/126150 13.70.00 %3.36 %4.21 % 10.0
Cyber Media (India) Ltd 22.7 Cr. 15.0 35.0/13.836.1 0.650.00 %45.5 %% 10.0
Industry Average2,440.31 Cr111.22182.0949.800.26%37.74%11.68%5.94

All Competitor Stocks of Saregama India Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 150180166185182204163172204263205242483
Expenses 96129114128119154113111139193154181399
Operating Profit 54515257634950616670516184
OPM % 36%29%31%31%35%24%31%35%32%27%25%25%17%
Other Income 8191011151718131518121316
Interest 1111121010000
Depreciation 44446678912131415
Profit before tax 58645663715859667076515984
Tax % 25%25%26%25%26%25%27%27%25%29%27%24%26%
Net Profit 44484247534443485254374562
EPS in Rs 2.252.502.172.412.762.272.252.492.712.791.912.333.23

Last Updated: February 28, 2025, 5:20 pm

Below is a detailed analysis of the quarterly data for Saregama India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹483.00 Cr.. The value appears strong and on an upward trend. It has increased from 242.00 Cr. (Sep 2024) to ₹483.00 Cr., marking an increase of ₹241.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹399.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Sep 2024) to ₹399.00 Cr., marking an increase of ₹218.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹84.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Sep 2024) to ₹84.00 Cr., marking an increase of ₹23.00 Cr..
  • For OPM %, as of Dec 2024, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 25.00% (Sep 2024) to 17.00%, marking a decrease of 8.00%.
  • For Other Income, as of Dec 2024, the value is ₹16.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Sep 2024) to ₹16.00 Cr., marking an increase of ₹3.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Sep 2024) to ₹15.00 Cr., marking an increase of ₹1.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹84.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Sep 2024) to ₹84.00 Cr., marking an increase of ₹25.00 Cr..
  • For Tax %, as of Dec 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Sep 2024) to 26.00%, marking an increase of 2.00%.
  • For Net Profit, as of Dec 2024, the value is ₹62.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Sep 2024) to ₹62.00 Cr., marking an increase of ₹17.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 3.23. The value appears strong and on an upward trend. It has increased from ₹2.33 (Sep 2024) to 3.23, marking an increase of ₹0.90.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 2:57 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 1861771872222183575455214425767378031,194
Expenses 170160184209209320507461312377516554927
Operating Profit 16172139363860130199221249267
OPM % 9%10%1%6%4%10%7%12%29%35%30%31%22%
Other Income 711112131056113123546158
Interest 3310237735631
Depreciation 133654435613213653
Profit before tax 7226916398560152204248271270
Tax % -3%23%-5%25%46%27%36%28%25%25%25%27%
Net Profit 717679285444113153185198198
EPS in Rs 0.471.090.390.390.481.643.112.536.477.919.6010.2410.26
Dividend Payout % 32%14%39%38%31%18%10%6%31%38%31%39%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)142.86%-64.71%16.67%28.57%211.11%92.86%-18.52%156.82%35.40%20.92%7.03%
Change in YoY Net Profit Growth (%)0.00%-207.56%81.37%11.90%182.54%-118.25%-111.38%175.34%-121.42%-14.48%-13.89%

Saregama India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:8%
3 Years:22%
TTM:61%
Compounded Profit Growth
10 Years:28%
5 Years:30%
3 Years:21%
TTM:6%
Stock Price CAGR
10 Years:44%
5 Years:79%
3 Years:2%
1 Year:33%
Return on Equity
10 Years:14%
5 Years:15%
3 Years:14%
Last Year:14%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 7:43 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 17171717171717171719191919
Reserves 951481501573223644113814881,3581,3231,4501,534
Borrowings 611384316641011155
Other Liabilities 71657289137181217211277309361559749
Total Liabilities 2452442472674805787096207841,6881,7042,0342,307
Fixed Assets 891028485199197215219226278338742789
CWIP 0000000022460
Investments 4040404013215114875137676239118137
Other Assets 1161011241431492303453254207321,1241,1681,381
Total Assets 2452442472674805787096207841,6881,7042,0342,307

Below is a detailed analysis of the balance sheet data for Saregama India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹19.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹1,534.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,450.00 Cr. (Mar 2024) to ₹1,534.00 Cr., marking an increase of 84.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹5.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹5.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹749.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹559.00 Cr. (Mar 2024) to ₹749.00 Cr., marking an increase of 190.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹2,307.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,034.00 Cr. (Mar 2024) to ₹2,307.00 Cr., marking an increase of 273.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹789.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹742.00 Cr. (Mar 2024) to ₹789.00 Cr., marking an increase of 47.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹6.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 6.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹137.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹118.00 Cr. (Mar 2024) to ₹137.00 Cr., marking an increase of 19.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹1,381.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,168.00 Cr. (Mar 2024) to ₹1,381.00 Cr., marking an increase of 213.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹2,307.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,034.00 Cr. (Mar 2024) to ₹2,307.00 Cr., marking an increase of 273.00 Cr..

Notably, the Reserves (₹1,534.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +627332-4-19-3679190949393
Cash from Investing Activity +-4-4-1-400-6-5-136-630-15432
Cash from Financing Activity +-1-25-6-8-3938-72-49677-75-85
Net Cash Flow0-2-420-7-10-424142-13640

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-45.004.00-6.009.006.0020.00-26.0050.00129.00198.00220.00244.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days7277106768775747672687372
Inventory Days1,030270266376
Days Payable838165114147
Cash Conversion Cycle72771067687757476264173226302
Working Capital Days444277235978120104358498122
ROCE %8%14%4%11%7%11%20%15%34%23%19%20%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters57.65%58.49%58.49%58.49%58.49%58.83%59.09%59.09%59.09%59.22%59.38%59.50%
FIIs17.09%17.30%17.24%17.47%17.70%17.79%17.12%16.81%16.05%17.22%17.29%15.70%
DIIs3.09%2.67%2.66%2.65%2.43%2.27%2.38%2.62%2.58%3.22%4.00%4.68%
Public22.07%21.44%21.47%21.23%21.13%20.86%21.15%21.22%22.00%20.07%19.08%19.90%
Others0.10%0.10%0.11%0.15%0.24%0.24%0.26%0.26%0.26%0.26%0.24%0.24%
No. of Shareholders45,33160,75363,53063,53664,67169,38172,90377,33872,43362,69865,62973,232

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Tata Retirement Savings Fund - Progressive Plan - Regular Plan451,9600.9716.7551,1152025-03-10784.2%
Union Innovation & Opportunities Fund292,9621.9110.8651,1152025-03-10473.14%
LIC MF Multi Cap Fund216,4630.998.0251,1152025-03-10323.48%
WhiteOak Capital Flexi Cap Fund185,8550.246.8951,1152025-03-10263.6%
WhiteOak Capital Mid Cap Fund142,9960.375.351,1152025-03-10179.75%
360 ONE FlexiCap Fund129,1111.454.7951,1152025-03-10152.59%
360 ONE Balanced Hybrid Fund88,4500.653.2851,1152025-03-1073.04%
WhiteOak Capital Multi Cap Fund52,1510.331.9351,1152025-03-102.03%
Nippon India Nifty Smallcap 250 Index Fund51,1150.21.8951,1152025-03-100%
Motilal Oswal Nifty Smallcap 250 Index Fund31,9430.21.1851,1152025-03-10-37.51%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.0010.0010.00
Basic EPS (Rs.) 10.279.638.4365.6125.29
Diluted EPS (Rs.) 10.279.638.4264.9725.26
Cash EPS (Rs.) 12.1210.688.6068.3227.62
Book Value[Excl.RevalReserv]/Share (Rs.) 70.6264.0371.62292.01230.14
Book Value[Incl.RevalReserv]/Share (Rs.) 76.3769.7871.62292.01230.14
Revenue From Operations / Share (Rs.) 41.6538.2030.11253.59299.25
PBDIT / Share (Rs.) 16.0914.2411.5292.3641.15
PBIT / Share (Rs.) 14.2113.1610.8489.1438.48
PBT / Share (Rs.) 14.0412.8710.6087.1634.63
Net Profit / Share (Rs.) 10.259.607.9265.1024.96
NP After MI And SOA / Share (Rs.) 10.259.617.9164.5825.21
PBDIT Margin (%) 38.6337.2738.2436.4213.74
PBIT Margin (%) 34.1234.4535.9835.1512.86
PBT Margin (%) 33.7233.6735.2034.3711.57
Net Profit Margin (%) 24.6025.1226.2825.678.34
NP After MI And SOA Margin (%) 24.6025.1626.2825.468.42
Return on Networth / Equity (%) 14.5415.0511.0722.2511.01
Return on Capital Employeed (%) 15.7718.1714.4827.5214.89
Return On Assets (%) 9.7110.879.0414.357.08
Total Debt / Equity (X) 0.000.000.000.000.02
Asset Turnover Ratio (%) 0.420.430.460.620.75
Current Ratio (X) 4.124.075.011.971.88
Quick Ratio (X) 3.313.534.581.651.32
Dividend Payout Ratio (NP) (%) 39.0331.2037.9033.290.00
Dividend Payout Ratio (CP) (%) 32.9928.0534.9031.710.00
Earning Retention Ratio (%) 60.9768.8062.1066.710.00
Cash Earning Retention Ratio (%) 67.0171.9565.1068.290.00
Interest Coverage Ratio (X) 95.6848.0549.1346.6510.68
Interest Coverage Ratio (Post Tax) (X) 61.9433.3834.7833.887.48
Enterprise Value (Cr.) 6139.985870.3592776.362636.35344.47
EV / Net Operating Revenue (X) 7.657.97159.795.970.66
EV / EBITDA (X) 19.7921.38417.8516.384.80
MarketCap / Net Operating Revenue (X) 8.318.65160.346.290.65
Retention Ratios (%) 60.9668.7962.0966.700.00
Price / BV (X) 4.925.1867.575.490.85
Price / Net Operating Revenue (X) 8.318.65160.346.290.65
EarningsYield 0.020.020.000.040.12

After reviewing the key financial ratios for Saregama India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 10.27. This value is within the healthy range. It has increased from 9.63 (Mar 23) to 10.27, marking an increase of 0.64.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 10.27. This value is within the healthy range. It has increased from 9.63 (Mar 23) to 10.27, marking an increase of 0.64.
  • For Cash EPS (Rs.), as of Mar 24, the value is 12.12. This value is within the healthy range. It has increased from 10.68 (Mar 23) to 12.12, marking an increase of 1.44.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 70.62. It has increased from 64.03 (Mar 23) to 70.62, marking an increase of 6.59.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 76.37. It has increased from 69.78 (Mar 23) to 76.37, marking an increase of 6.59.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 41.65. It has increased from 38.20 (Mar 23) to 41.65, marking an increase of 3.45.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 16.09. This value is within the healthy range. It has increased from 14.24 (Mar 23) to 16.09, marking an increase of 1.85.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 14.21. This value is within the healthy range. It has increased from 13.16 (Mar 23) to 14.21, marking an increase of 1.05.
  • For PBT / Share (Rs.), as of Mar 24, the value is 14.04. This value is within the healthy range. It has increased from 12.87 (Mar 23) to 14.04, marking an increase of 1.17.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 10.25. This value is within the healthy range. It has increased from 9.60 (Mar 23) to 10.25, marking an increase of 0.65.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.25. This value is within the healthy range. It has increased from 9.61 (Mar 23) to 10.25, marking an increase of 0.64.
  • For PBDIT Margin (%), as of Mar 24, the value is 38.63. This value is within the healthy range. It has increased from 37.27 (Mar 23) to 38.63, marking an increase of 1.36.
  • For PBIT Margin (%), as of Mar 24, the value is 34.12. This value exceeds the healthy maximum of 20. It has decreased from 34.45 (Mar 23) to 34.12, marking a decrease of 0.33.
  • For PBT Margin (%), as of Mar 24, the value is 33.72. This value is within the healthy range. It has increased from 33.67 (Mar 23) to 33.72, marking an increase of 0.05.
  • For Net Profit Margin (%), as of Mar 24, the value is 24.60. This value exceeds the healthy maximum of 10. It has decreased from 25.12 (Mar 23) to 24.60, marking a decrease of 0.52.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 24.60. This value exceeds the healthy maximum of 20. It has decreased from 25.16 (Mar 23) to 24.60, marking a decrease of 0.56.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 14.54. This value is below the healthy minimum of 15. It has decreased from 15.05 (Mar 23) to 14.54, marking a decrease of 0.51.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 15.77. This value is within the healthy range. It has decreased from 18.17 (Mar 23) to 15.77, marking a decrease of 2.40.
  • For Return On Assets (%), as of Mar 24, the value is 9.71. This value is within the healthy range. It has decreased from 10.87 (Mar 23) to 9.71, marking a decrease of 1.16.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.42. It has decreased from 0.43 (Mar 23) to 0.42, marking a decrease of 0.01.
  • For Current Ratio (X), as of Mar 24, the value is 4.12. This value exceeds the healthy maximum of 3. It has increased from 4.07 (Mar 23) to 4.12, marking an increase of 0.05.
  • For Quick Ratio (X), as of Mar 24, the value is 3.31. This value exceeds the healthy maximum of 2. It has decreased from 3.53 (Mar 23) to 3.31, marking a decrease of 0.22.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 39.03. This value is within the healthy range. It has increased from 31.20 (Mar 23) to 39.03, marking an increase of 7.83.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 32.99. This value is within the healthy range. It has increased from 28.05 (Mar 23) to 32.99, marking an increase of 4.94.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 60.97. This value is within the healthy range. It has decreased from 68.80 (Mar 23) to 60.97, marking a decrease of 7.83.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 67.01. This value is within the healthy range. It has decreased from 71.95 (Mar 23) to 67.01, marking a decrease of 4.94.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 95.68. This value is within the healthy range. It has increased from 48.05 (Mar 23) to 95.68, marking an increase of 47.63.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 61.94. This value is within the healthy range. It has increased from 33.38 (Mar 23) to 61.94, marking an increase of 28.56.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 6,139.98. It has increased from 5,870.35 (Mar 23) to 6,139.98, marking an increase of 269.63.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 7.65. This value exceeds the healthy maximum of 3. It has decreased from 7.97 (Mar 23) to 7.65, marking a decrease of 0.32.
  • For EV / EBITDA (X), as of Mar 24, the value is 19.79. This value exceeds the healthy maximum of 15. It has decreased from 21.38 (Mar 23) to 19.79, marking a decrease of 1.59.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.31. This value exceeds the healthy maximum of 3. It has decreased from 8.65 (Mar 23) to 8.31, marking a decrease of 0.34.
  • For Retention Ratios (%), as of Mar 24, the value is 60.96. This value is within the healthy range. It has decreased from 68.79 (Mar 23) to 60.96, marking a decrease of 7.83.
  • For Price / BV (X), as of Mar 24, the value is 4.92. This value exceeds the healthy maximum of 3. It has decreased from 5.18 (Mar 23) to 4.92, marking a decrease of 0.26.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.31. This value exceeds the healthy maximum of 3. It has decreased from 8.65 (Mar 23) to 8.31, marking a decrease of 0.34.
  • For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Saregama India Ltd as of March 12, 2025 is: ₹442.07

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Saregama India Ltd is Overvalued by 9.97% compared to the current share price 491.00

Intrinsic Value of Saregama India Ltd as of March 12, 2025 is: 484.77

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Saregama India Ltd is Overvalued by 1.27% compared to the current share price 491.00

Last 5 Year EPS CAGR: 9.66%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 15.50%, which is a positive sign.
  2. The company has higher reserves (629.31 cr) compared to borrowings (14.77 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (382.46 cr) and profit (106.85 cr) over the years.
  1. The stock has a high average Working Capital Days of 73.83, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 134.00, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Saregama India Ltd:
    1. Net Profit Margin: 24.6%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 15.77% (Industry Average ROCE: 37.74%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 14.54% (Industry Average ROE: 11.68%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 61.94
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.31
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 47.9 (Industry average Stock P/E: 182.09)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Saregama India Ltd. is a Public Limited Listed company incorporated on 13/08/1946 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L22213WB1946PLC014346 and registration number is 014346. Currently Company is involved in the business activities of Sound recording and music publishing activities. Company's Total Operating Revenue is Rs. 758.77 Cr. and Equity Capital is Rs. 19.28 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Entertainment & Media33, Jessore Road, Dum Dum, Kolkata West Bengal 700028co.sec@saregama.com
http://www.saregama.com
Management
NamePosition Held
Dr. Sanjiv GoenkaChairman & Non-Exe.Director
Mrs. Avarna JainVice Chairman & Non Exe.Dire
Mr. Vikram MehraManaging Director
Mrs. Preeti GoenkaNon Executive Director
Mr. Santanu BhattacharyaInd. Non-Executive Director
Mr. Noshir Naval FramjeeInd. Non-Executive Director
Mr. Umang KanoriaInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Saregama India Ltd?

The latest intrinsic value of Saregama India Ltd as on 11 March 2025 is ₹442.07, which is 9.97% lower than the current market price of 491.00, indicating the stock is overvalued by 9.97%. The intrinsic value of Saregama India Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹9,475 Cr. and recorded a high/low of ₹689/339 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,534 Cr and total liabilities of ₹2,307 Cr.

What is the Market Cap of Saregama India Ltd?

The Market Cap of Saregama India Ltd is 9,475 Cr..

What is the current Stock Price of Saregama India Ltd as on 11 March 2025?

The current stock price of Saregama India Ltd as on 11 March 2025 is ₹491.

What is the High / Low of Saregama India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Saregama India Ltd stocks is ₹689/339.

What is the Stock P/E of Saregama India Ltd?

The Stock P/E of Saregama India Ltd is 47.9.

What is the Book Value of Saregama India Ltd?

The Book Value of Saregama India Ltd is 80.5.

What is the Dividend Yield of Saregama India Ltd?

The Dividend Yield of Saregama India Ltd is 0.92 %.

What is the ROCE of Saregama India Ltd?

The ROCE of Saregama India Ltd is 19.6 %.

What is the ROE of Saregama India Ltd?

The ROE of Saregama India Ltd is 14.2 %.

What is the Face Value of Saregama India Ltd?

The Face Value of Saregama India Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Saregama India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE